Baldemia is helping the triage of CF community servicing companies and foundations in building new initiatives in 2015 that will improve quality of life and health outcomes for people and families dealing with cystic fibrosis. Here is a glimpse of our planned activities for the CFTechnology Foundation in 2015. Chris Baldwin (CEO at Baldemia) is the acting CEO of CysticFibrosis.com, Medrise and the CFTechnology Foundation (See History).
The CFTechnology Foundation (CFTechnology.org), a 501(c)3 non-profit foundation is working with a consortium of mHealth companies to get technology into the hands of people with cystic fibrosis to capture as much real-time biometric, behavioral, attitudinal, demographic, environmental, historic and genetic information as possible. The technology will provide tools for personal mastery of care management routines and the achievement of goals for daily living. The data can be collected using the latest wifi-enabled devices, in-home sensors and voice-enabled applications. The information can connect the universe of caregivers, and be merged with existing medical and profile information so that on-going big data analyses can generate insights that will lead to a better understanding of the condition, better treatment protocols for managing it, more timely and appropriate care delivery, and ultimately better health outcomes.
For a summary of what the different entities do and our value proposition, you can visit our collaboration presentation here.